Endometrial Neoplasms × Other hematologic neoplasm × 30 days × Clear all
NCT02465060 2026-05-26

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
6,452 enrolled 1 FDA
NCT02012699 2026-05-05

iCaRe2

University of Nebraska

Recruiting
999,999 enrolled